A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

Clinical trial NCT04855929 · COMPLETED

Trial details

NCT number: NCT04855929
Sponsor: Anaveon AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Adult Disease Lung Cancer

Start date: 2021-05-25
Primary completion: 2024-07-18
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.